Drug Metabolism/Pharmacology

Top Story

Daily aspirin use reduces risk for fibrosis progression in NAFLD

May 16, 2019
Meeting News

HCV vaccine using chimp adenovirus shows promise in healthy humans

April 12, 2019
VIENNA — Use of adenovirus derived from chimpanzees showed increased activity and sustainability of T cell activation in an early study of a vaccine for hepatitis…
In the Journals

Acetaminophen undetectable in more than half of related DILI cases

February 11, 2019
More than half of patients who presented in hospital with acetaminophen-induced acute liver injury or acute liver failure had undetectable levels of acetaminophen…

CAMP4, Alnylam partner to identify rare liver disease genetic targets

January 24, 2019
CAMP4 Therapeutics and Alnylam Pharmaceuticals announced a collaboration designed to identify new medication targets of an undisclosed rare liver disease with…
More Headlines »

Cirrhosis and Hepatic Encephalopathy – Managing Their Consequences and Complications

This activity is supported by an educational grant from Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC.

Cirrhosis, or advanced fibrosis of the liver, can lead to serious health sequelae or death. However, substantial…
More »
GI Bookshelf

Question 28: I Have A Patient With Biliary-Type Pain, But No Other Evidence Of Bile Duct Disease (Normal Diameter Duct On Ultrasound, Normal Liver Function Tests). How Should Such A Patient Be Managed?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Meeting News

VIDEO: Physicians must directly discuss complementary medications

November 16, 2017
More »